Portsmouth, NH — Liberty Vision is proud to announce the launch of the 10mm LV Y-90 Disc and new 10mm sizes for both the iWand® A and iWand® P applicators. These additions expand the treatment options available to ocular oncologists and radiation oncologists, enabling more precise care for a broader range of patients.

Broader Coverage for More Patients

The LV Y-90 Disc is an FDA-cleared high-dose-rate beta radiation source indicated for episcleral brachytherapy of tumors and benign growths and has been used to treat a variety of conditions including iris melanoma, iridociliary melanoma, choroidal melanoma, and squamous carcinoma. The new 10mm disc gives clinicians an additional size option to better match applicator coverage to tumor geometry — improving dose conformity while minimizing radiation to surrounding healthy tissue.

The 10mm size is now available across both iWand models. Both are hand-held, pre-sterilized, single-use applicators. The iWand A is designed for anterior segment disease, offering a see-through polymer shield that protects the surgeon while maintaining a clear view of the target.

The iWand P is optimized for posterior placement and features four surrounding guide lights that allow the surgeon to confirm disc position using ophthalmoscopy.

Availability

The 10mm LV Y-90 Disc, iWand A, and iWand P are now available. Physicians and institutions interested in learning more or placing an order are encouraged to contact Liberty Vision directly.

Contact: Liberty Vision, 300 West Road, Unit 2, Portsmouth, NH 03801 · Phone: 603-319-8416 · Email: mail@libertyvision.com

Liberty Vision is a medical device company dedicated to advancing brachytherapy for ocular oncology. Its Y-90 Disc and iWand® product lines are used by leading eye cancer centers across the United States.